DCF — ST. RITAS MEDICAL CENTER LLC
Enterprise Value: $236.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$236.5M
Enterprise Value
$56.9M
PV of Cash Flows
$179.6M
PV of Terminal Value
$289.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $512.5M | $35.6M | 7.0% | $8.2M | $7.5M |
| Year 2 | $527.9M | $42.0M | 8.0% | $12.4M | $10.3M |
| Year 3 | $543.7M | $48.7M | 9.0% | $16.9M | $12.7M |
| Year 4 | $560.0M | $52.9M | 9.0% | $19.5M | $13.3M |
| Year 5 | $576.8M | $56.0M | 10.0% | $21.2M | $13.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $236.5M. Terminal value accounts for 76% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$497.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0645295364446918
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5